Aduro Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Aduro Biotech and buy or sell other stocks, ETFs, and their options commission-free!

About ADRO

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. 

CEO
Stephen T. Isaacs
CEOStephen T. Isaacs
Employees
214
Employees214
Headquarters
Berkeley, California
HeadquartersBerkeley, California
Founded
2008
Founded2008
Employees
214
Employees214

ADRO Key Statistics

Market cap
955.55M
Market cap955.55M
Price-Earnings ratio
-7.50
Price-Earnings ratio-7.50
Dividend yield
—
Dividend yield—
Average volume
422.35K
Average volume422.35K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$27.44
52 Week high$27.44
52 Week low
$12.41
52 Week low$12.41
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.